Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sarah Cadot"'
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/a35cc62ebfd74f2194b22c29b2f7c193
Autor:
Sarah Cadot, Chloe Audebert, Charlotte Dion, Soleakhena Ken, Loic Dupré, Laetitia Largeaud, Camille Laurent, Loic Ysebaert, Fabien Crauste, Anne Quillet-Mary
Publikováno v:
PLoS Medicine, Vol 21, Iss 7, p e1004430 (2024)
BackgroundOne of the first clinical observations of ibrutinib activity in the treatment of chronic lymphocytic leukemia (CLL) is a rapid decline in lymph nodes size. This phenomenon is accompanied by an hyperlymphocytosis, either transient or prolong
Externí odkaz:
https://doaj.org/article/f17d8dafc0d34daa9927d03be3be13de
Autor:
Javier Rey-Barroso, Alice Munaretto, Nelly Rouquié, Aurélie Mougel, Malika Chassan, Sébastien Gadat, Océane Dewingle, Renaud Poincloux, Sarah Cadot, Loïc Ysebaert, Anne Quillet-Mary, Loïc Dupré
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is widely used for treatment of patients with relapsed/refractory or treatment-naïve chronic lymphocytic leukemia (CLL). A prominent effect of ibrutinib is to disrupt the retention of CLL cells fr
Externí odkaz:
https://doaj.org/article/29c100f1121c45a9b80d70916791602f
Autor:
Sarah Cadot, Carine Valle, Marie Tosolini, Frederic Pont, Laetitia Largeaud, Camille Laurent, Jean Jacques Fournie, Loic Ysebaert, Anne Quillet-Mary
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-13 (2020)
Abstract Background Ibrutinib, an irreversible Bruton Tyrosine Kinase (BTK) inhibitor, has revolutionized Chronic Lymphocytic Leukemia (CLL) treatment, but resistances to ibrutinib have emerged, whether related or not to BTK mutations. Patterns of CL
Externí odkaz:
https://doaj.org/article/e2fc737158c04f7ba4a2fdea4933707f
Autor:
Nicolas Curdy, Olivia Lanvin, Sarah Cadot, Camille Laurent, Jean-Jacques Fournié, Don-Marc Franchini
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2021)
Immune cell activation triggers transcriptional and translational programs eliciting cellular processes, such as differentiation or proliferation, essential for an efficient immune response. These dynamic processes require an intricate orchestration
Externí odkaz:
https://doaj.org/article/6eed090c3d4943ee9d0f3e5e29acd06a
Autor:
Cedric Garcia, Sebastien Dejean, Nicolas Savy, Jean-Claude Bordet, Jennifer Series, Sarah Cadot, Agnès Ribes, Sophie Voisin, Lucia Rugeri, Bernard Payrastre, Pierre Sié
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. :100180
Autor:
Frédéric Martins, Sarah Cadot, Carine Valle, Mary Poupot, Marie Tosolini, Anne Quillet-Mary, Francesco Dieli, Camille Laurent, Serena Meraviglia, Jean-Jacques Fournié, Pierre Milpied, Gabriele Pizzolato, Delphine Labourdette, Julie Déchanet-Merville, Don-Marc Franchini, Hannah Kaminski, Loic Ysebaert, Frédéric Pont, Pierre Merville
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, pp.201818488. ⟨10.1073/pnas.1818488116⟩
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (24), pp.11906-11915. ⟨10.1073/pnas.1818488116⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, 116 (24), pp.11906-11915. ⟨10.1073/pnas.1818488116⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, pp.201818488. ⟨10.1073/pnas.1818488116⟩
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (24), pp.11906-11915. ⟨10.1073/pnas.1818488116⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, 116 (24), pp.11906-11915. ⟨10.1073/pnas.1818488116⟩
γδ T lymphocytes represent ∼1% of human peripheral blood mononuclear cells and even more cells in most tissues of vertebrates. Although they have important anticancer functions, most current single-cell RNA sequencing (scRNA-seq) studies do not i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64db1e695214bd00ce34bd243f2eaed3
https://hal.archives-ouvertes.fr/hal-02347491
https://hal.archives-ouvertes.fr/hal-02347491
Autor:
Marie Levade, Elodie David, Pierre-Alexandre Laurent, Loic Ysebaert, Anne-Sophie Michallet, Constantine S. Tam, Sarah Cadot, Cédric Garcia, Pierre Sié, Jean-Claude Bordet, Bernard Payrastre
Publikováno v:
Blood. 124:3991-3995
The oral Bruton's tyrosine kinase inhibitor, ibrutinib, has recently demonstrated high efficiency in patients with relapsed B-cell malignancies. Occurrence of bleeding events has been reported in a subgroup of ibrutinib-treated patients. We demonstra
Autor:
Melanie White-Koning, Loic Ysebaert, Camille Vinson, Fanny Gallais, Caroline Protin, Fabien Despas, Sandra De Barros, Lucie Oberic, Etienne Chatelut, Sarah Cadot, Anne Calleja, Christian Recher, Anne Quillet Mary
Publikováno v:
Blood
Blood, American Society of Hematology, 2018, 132 (Supplement 1), pp.3960-3960. ⟨10.1182/blood-2018-99-116532⟩
Blood, American Society of Hematology, 2018, 132 (Supplement 1), pp.3960-3960. ⟨10.1182/blood-2018-99-116532⟩
Introduction: Therapeutic drug monitoring (TDM) entails the measurement of drug concentrations and the individualization of drug dosages or schedules to maximize therapeutic effects and minimize toxicity. Ibrutinib (IBR), the first-in-class inhibitor
Autor:
Nathalie Arbour, Sarah L. Peyrard, Robert H. Brown, Christine Vande Velde, Sarah Cadot, Jean-Pierre Julien, Laurie Destroismaisons, Sarah Pickles, Guy A. Rouleau
Publikováno v:
Molecular Neurodegeneration
Mutant superoxide dismutase 1 (SOD1) selectively associates with spinal cord mitochondria in rodent models of SOD1-mediated amyotrophic lateral sclerosis. A portion of mutant SOD1 exists in a non-native/misfolded conformation that is selectively reco